When cure is care: diagnosis and management of pulmonary arterial hypertension.

Brian Widmar
{"title":"When cure is care: diagnosis and management of pulmonary arterial hypertension.","authors":"Brian Widmar","doi":"10.111/j.1041-2972.2005.0018.x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this article is to provide nurse practitioners with an understanding of the pathophysiology of pulmonary arterial hypertension (PAH) disease, clinical manifestations, diagnostic evaluation, drug therapy, strategies for health promotion, and relevant care issues for patients and families.</p><p><strong>Data sources: </strong>Selected clinical and research articles, as well as current government guidelines.</p><p><strong>Conclusions: </strong>Symptoms expressed are more apparent as PAH disease progresses, leaving fewer treatment options in advanced disease stages. New drugs are currently being tested for the treatment of PAH; however, the costs of many of the currently approved treatments may be prohibitive.</p><p><strong>Implications for practice: </strong>Earlier recognition of disease symptoms leads to prompt initiation of diagnostic evaluation and referral to specializing medical centers. Upon referral, specialty centers may begin appropriate treatment regimens earlier in the disease process, which could improve clinical outcomes and quality of life.</p>","PeriodicalId":50020,"journal":{"name":"Journal of the American Academy of Nurse Practitioners","volume":"17 3","pages":"104-12"},"PeriodicalIF":0.0000,"publicationDate":"2005-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.111/j.1041-2972.2005.0018.x","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Nurse Practitioners","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.111/j.1041-2972.2005.0018.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The purpose of this article is to provide nurse practitioners with an understanding of the pathophysiology of pulmonary arterial hypertension (PAH) disease, clinical manifestations, diagnostic evaluation, drug therapy, strategies for health promotion, and relevant care issues for patients and families.

Data sources: Selected clinical and research articles, as well as current government guidelines.

Conclusions: Symptoms expressed are more apparent as PAH disease progresses, leaving fewer treatment options in advanced disease stages. New drugs are currently being tested for the treatment of PAH; however, the costs of many of the currently approved treatments may be prohibitive.

Implications for practice: Earlier recognition of disease symptoms leads to prompt initiation of diagnostic evaluation and referral to specializing medical centers. Upon referral, specialty centers may begin appropriate treatment regimens earlier in the disease process, which could improve clinical outcomes and quality of life.

当治疗是护理:肺动脉高压的诊断和处理。
目的:本文旨在帮助护理人员了解肺动脉高压(PAH)疾病的病理生理、临床表现、诊断评价、药物治疗、健康促进策略以及患者和家属的相关护理问题。数据来源:选定的临床和研究文章,以及当前的政府指南。结论:随着多环芳烃疾病的进展,症状表现更为明显,在疾病晚期,治疗选择较少。目前正在试验治疗多环芳烃的新药;然而,许多目前批准的治疗方法的费用可能令人望而却步。对实践的启示:早期识别疾病症状导致迅速启动诊断评估和转诊到专业医疗中心。在转诊后,专科中心可以在疾病过程的早期开始适当的治疗方案,这可以改善临床结果和生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信